Commvault Systems (CVLT) presents a materially negative liquidation recovery posture as of December 31, 2025, consistent with the profile of an asset-light software business whose balance sheet value is concentrated in contractual relationships rather than tangible assets. Under liquidation-lens haircuts, the asset side recovers poorly: cash of $1.03B recovers at par (100%), accounts receivable of $362M at 90-95% yields roughly $325-344M, PP&E of $11M at 50-70% yields roughly $6-8M, and all intangibles (goodwill $211M, finite-lived intangibles $21M, capitalized contract costs $95M, deferred tax assets $152M, right-of-use assets $38M, and other non-current assets $66M) are zeroed. Total liquidation-basis asset recovery is approximately $1.36-1.38B. Against this, liabilities at face value include: current liabilities of $617M (comprising deferred revenue current $457M, accrued liabilities $153M, operating lease current $7M, and other), non-current deferred revenue $276M, convertible notes $900M face ($880M net carrying), operating lease non-current $32M, deferred tax liabilities $2M, other non-current liabilities $15M, and restructuring reserve $7M. Total face-value obligations are approximately $1.85B, yielding a liquidation deficit to equity of approximately negative $470-490M. This is a structurally negative liquidation recovery driven almost entirely by the new $900M 0% convertible senior notes issued September 5, 2025 at face, which must be repaid in cash at maturity (September 2030) or upon fundamental change/conversion, and the massive deferred revenue liability ($733M combined current and non-current) which extinguishes no faster on wind-up than on a going-concern basis. The dominant change since the prior filing (10-Q for quarter ended September 30, 2025) is not structural — the Notes were already on the balance sheet in Q2. Between September 30 and December 31, 2025 cash declined from $1.06B to $1.03B, driven by ongoing share repurchases ($40.7M in Q3 FY26), partially offset by operating cash generation. Deferred revenue continued to grow, adding to the liability stack. A new restructuring plan (Plan B) was initiated in Q3 FY26 with up to $30M expected total cost, with $11.7M charged in Q3; approximately $20M in additional charges are disclosed as anticipated, creating an incremental but not balance-sheet-altering liability accretion. The MFFAIS CLV of $378M and LLV/OLV of $740M reflect cash-heavy recovery; the practitioner estimate above is consistent with MFFAIS LLV range when deferred revenue is treated as a full face-value obligation. Filing discusses ARR, Subscription ARR, and SaaS NRR as operating KPIs in MD&A but does not separately tag these metrics in XBRL.
▼ Community Notes